Stock Quote
Gen Probe Inc (GPRO.O) (Nasdaq)
sector: Healthcare .
industry: Medical Equipment, Supplies & Distribution ยท
View GPRO on other exchanges
$42.32
11:45am EST
+1.46%
$41.71
$42.00
96,796
$42.90
$41.80
$49.29
$31.97
0.88
459,012
GPRO.O
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Nordhoff, Henry | Non-Executive Chairman of the Board | 4,052,130 |
| Hull, Carl | Chief Executive Officer, Director | 1,772,660 |
| Rosenman, Herm | Chief Financial Officer, Senior Vice President - Finance | 1,074,140 |
Profile
Gen-Probe Incorporated (Gen-Probe) is engaged in the development, manufacture and marketing of nucleic acid probe-based products used for the clinical diagnosis of human diseases and for screening donated human blood. It also develops and manufactures nucleic acid probe-based products for the... Full Description
Company Address
Gen Probe Inc
10210 Genetic Center Drive
San Diego CA 92121
P: +1858.4108000
F: +1800.2883141
10210 Genetic Center Drive
San Diego CA 92121
P: +1858.4108000
F: +1800.2883141
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Roche Holding Ltd. | CHF166.20 | +3.50 |
| Roche Holding Ltd. | CHF168.70 | +1.40 |
| Abbott Laboratories | $53.29 | -0.35 |
| GPRO.O | Industry | |
|---|---|---|
| P/E(TTM) | 24.52 | 3.76 |
| P/S(TTM) | 4.37 | 0.51 |
| ROI(TTM) | 11.03 | 2.54 |
| ROE(TTM) | 11.27 | 4.01 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | 0.52 |
| EPS Est. (Current Year) | 1.92 |
| Total Revenue | $122.70M |
| Net Income | $22.20M |
| EPS | $0.44 |
